Dr. Isabel White
Chaired by Prof. Julia Downing and Prof. Raymond Chan
Dr. Isabel White is an experienced research active clinician, in cancer nursing and psychosexual therapy, who has worked in supportive care and psychological support in oncology within the university, public health care and charitable (third) sectors.
She works collaboratively to promote practice development, training, clinical audit, service evaluation and research initiatives that aim to enhance quality of care and services for people experiencing the sexual consequences of cancer and its treatment.
Isabel’s clinical and research interests include the development and evaluation of sexual wellbeing assessment methods in practice, health professional training interventions and the clinical management of sexual consequences.
She works to raise the profile of this neglected aspect of cancer survivorship within practice, workforce education, research and policy for people living with and beyond cancer.
CME Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.
This talk outlines the most common male and female sexual difficulties that arise as a direct or indirect consequence of cancer diagnosis and treatment. Factors affecting clinical assessment and health professional/patient communication about treatment-induced sexual difficulties will then be explored. The biomedical, behavioural and other therapeutic strategies available to improve sexual rehabilitation after cancer treatment will also be addressed in detail. Finally, theoretical, practical and evidence-based approaches are combined, thus offering an integrated approach to comprehensively address this often neglected yet important aspect of cancer survivorship.
By the end of this lecture the attendee will be able to:
- Define the most common treatment-induced sexual difficulties affecting men and women living with and beyond cancer.
- Consider the socio-cultural, individual and health care system factors that adversely affect oncology professional’s ability to discuss and support those experiencing sexual consequences of cancer and its treatment.
- Outline the biomedical and behavioural strategies that can assist in the integrated management of common male and female sexual difficulties after cancer treatment.
This lecture is equal to 1 CPD Point, 1 AMA PRA Category 1 Credit™, and 1 CE Contact Hour.
Additional CME Info
Release Date: February 1, 2020, Termination Date: January 31, 2023
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: EB Medicine designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per lecture. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This activity received no commercial support.
Earning Credit: In order to earn CME credit, the participant must take the pre-test, listen to the lecture, take the CME post-test, and complete the post-test evaluation.